IL2 and myeloid sarcoma: On the other hand, higher level of IP-10 (OR [95%CI] = 0.71 [0.55,0.91], P = 7.72E-03, P adjust = 1.62E-01) decreased the risk of MS, and higher level of IL-2 (OR [95%CI] = 1.26 [1.00,1.57], P = 4.61E-02, P adjust = 6.46E-01) increased the risk of MS with suggestive evidence (P < 0.05).